Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina

American Journal of Cardiology

Volumn 79, Issue 5, 1997, Pages 606-610

  Kugiyama, Kiyotaka ^a   Ohgushi, Masamichi ^a   Sugiyama, Seigo ^a   Motoyama, Takeshi ^a   Kawano, Hiroaki ^a   Hiroshima, Osamu ^a   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DILTIAZEM; GLYCERYL TRINITRATE; NITRIC OXIDE; VASODILATOR AGENT;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY SPASM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; THORAX PAIN;

ADULT; AGED; ANGINA PECTORIS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL AVAILABILITY; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; CORONARY VESSELS; CYCLIC GMP; DILTIAZEM; FEMALE; GUANYLATE CYCLASE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 0030971476     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00824-7     Document Type: Article

References (27)

1. Yasue H, Omote S, Takizawa A, Nagano M. Coronary arterial spasm in ischemic heart disease and its pathogenesis. Circ Res 1983;52(suppl. I):147-152.
2. Okumura K, Yasue H, Katsuyama K, Ogawa H, Kugiyama K, Ishizaka H, Sumida H, Fujii H, Matsunaga T, Tsunoda R. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996;27:45-52.
3. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H. Nitric oxide bioactivity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-272.
4. Feelisch M. The biochemical pathways of NO formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991;17(suppl 3):S25-S33.
5. Mulsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, Busse R. In vivo spin trapping of glyceryl tri nitrate-derived NO in rabbit blood vessels and organs. Circulation 1995;92:1876-1882.
6. Ignarro LJ. Biological action and properties of endothelium-derived NO formed and released from artery and vein. Circ Res 1989;65:1-21.
7. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther 1994;8:600-612.
8. Moncada S, Palmer RMJ, Higgs EA. NO: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
9. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cGMP system. J Cardiovasc Pharmacol 1988;12(supp. 5):S115-S118.
10. de Bold AJ. Atrial natriuretic factor, a hormone produced by the heart. Science 1985;230:767-770.
11. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endothelium-independent relaxation and activites particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 1984;81:7661-7664.
12. Okumura K, Yasue H, Matsuyama K, Matsuyama K, Morikami Y, Ogawa H, Obata K. Effect of HI receptor stimulation on coronary artery diameter in patients with variant angina: comparison with effect of acetylcholine. J Am Coll Cardiol 1991;17:338-345.
13. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment; possible role of early coronary atherosclerosis. Circulation 1990;81:482-490.
14. Nichols AB, Gabrieli CFO, Fenoglio JJ, Esser PD. Quantification of relative coronary arterial stenosis by videodensitometric analysis of the coronary angiograms. Circulation 1984;69:512-522.
15. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-963.
16. Bertrand ME, Dupuis BA, Lablanche JM, Tilmant PY, Thieuleux FA. Coronary hemodynamics following intravenous or intracoronary injection of diltiazem in man. J Cardiovasc Pharmacol 1982;4:695-699.
17. Tanaka H, Yasue H, Yoshimura M, Morita E, Jougasaki M, Kalo H, Miyao Y, Makao K. Suppression of hyperventilation-induced attacks with infusion of ANP in patients with variant angina pectoris. Am J Cardiol 1993;72:128-133.
18. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell NO synthase. J Clin Invest 1992;90:2092-2096.
19. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial NO synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Nail Acad Sci USA 1992;89:6348-6352.
20. Chu A, Chambers DE, Lin C, Kuehl WD, Palmer RMJ, Moncada S, Cobb FR. Effects of inhibition of NO formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991;87:1964-1968.
21. Vallance P, Collier J, Moncada S. Effects of endothelium-derived NO on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
22. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of NO synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
23. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon III RO, Johnson G, Mincemoyer R. NO activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-1755.
24. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular NO synthesis in vivo. Proc Natl Acad Sci USA 1991;88:2166-2170.
25. Waldman SA, Rapoport RM, Ginsberg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 1986;35:3525-3531.
26. Bull H, Buyssens N, De Meyer GR, Jordaens FH, Herman AG. Effects of chronic treatment with a source of exogenous NO on the release of endotheliumderived relaxing factor by aortae from normal and hypercholesterolaemic rabbits. In Moncada S, Higgs EA, eds. NO from L-Arginine: A Bioregulatory System. Amsterdam: Elsevier, 1990;101-106.
27. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular Superoxide anion production in nitrate tolerance, a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-194.